gp55-P is a dimeric membrane protein with a single transmembrane helix that is coded by the env gene of the polycythemic strain of the spleen focus forming virus. gp55-P activates the erythropoietin (Epo) receptor through specific transmembrane helix interactions, leading to Epo-independent growth of erythroid progenitors and eventually promoting erythroleukemia.
Introduction

4
How do the six TM sequence differences between gp55-P and gp55-A lead to functional differences between these two similar viral proteins? In principle, the sequence differences may cause changes in how the TM helices interact with one another within a gp55 dimer or in how the gp55 dimer interacts with the Epo receptor dimer. Both gp55-A and gp55-P are homodimers when expressed on the cell surface (21) as a result of disulfide bond formation between cysteines in their extracellular domains (2) . However, only the TM domain of gp55-P forms homodimers when assayed by the ToxR chloramphenicol acetyltransferase (TOXCAT) reporter system (21) . This suggests that the ability of gp55-P to activate the Epo receptor is related, at least in part, to the ability of the TM sequence of gp55-P to mediate tight helix-helix interactions.
The human Epo receptor is not activated by gp55-P. However, mutation of a single amino acid (Leu238) in the TM domain of the human receptor to serine, its counterpart in the mouse, allows it to be activated by gp55-P (22) . The converse mutation (Ser238Leu) in the mouse receptor eliminates its ability to be activated, indicating that Ser238 enables gp55-P activation of either the human or mouse receptor. Based on computational searches, we proposed that Met390 of gp55-P interacts specifically with Ser238 to activate the receptor (22) .
Mutation of Met390 to isoleucine (the amino acid at position 390 in gp55-A) eliminates the ability of gp55-P to activate human (Leu238Ser) and mouse Epo receptors (22) . In addition, the M390L mutation was reported to induce anemia, rather than polycythemia (23) . These observations suggest that the sequence differences between gp55-P and gp55-A also result in changes in specific TM contacts between gp55-P/A and the Epo receptor.
Here, we use deuterium NMR spectroscopy in combination with magic angle spinning (MAS) to determine the structure of the gp55-P TM dimer. The dimer structure provides a 5 framework for establishing the mechanism for how the TM region of gp55-P activates the Epo receptor, as well as for understanding how sequence differences in mutant viral proteins confer different phenotypes. Deuterium NMR spectroscopy takes advantage of the sensitivity of deuterium lineshapes to molecular motion (24) (25) (26) . We have previously shown that the motion of amino acids located in TM helix interfaces is restricted relative to amino acids oriented toward the lipid membrane (27) . As a result, by characterizing side chain motion as a function of the TM sequence, one can map out the interface of interacting TM helices. Typically, deuterium NMR lineshape analyses are carried out on static samples and have been used extensively to study lipid motion (28) . Studies of membrane proteins have been limited by low sensitivity. To overcome this problem, we take advantage of the increased sensitivity afforded by MAS to observe changes in the quadrupolar lineshape. We propose that deuterium MAS of consecutive leucine side chains in a TM sequence provides a simple approach for studying helix-helix interactions in membrane proteins. Together with results from polarized infrared (IR) spectroscopy and computational searches, the deuterium MAS spectra of specifically deuterated leucines in the TM sequence of gp55-P are used to establish its TM dimer structure.
Experimental Procedures
Materials.
Deuterated (5,5,5-D 3 ) leucine and deuterium-free water were purchased from Cambridge Isotope Laboratories (Andover, MA). Other amino acids and octyl-ß-glucoside were obtained from Sigma Chemical (St. Louis, MO). DMPC was obtained from Avanti Polar Lipids (Alabaster, AL) as a lyophilized powder and used without further purification.
Peptide synthesis and purification.
Peptides (33 residues in length) corresponding to the TM domain of gp55-P were synthesized using solid-phase methods at the W. M. Keck Peptide Synthesis Facility at Yale University. The sequence is largely hydrophobic with Arg and Trp/His defining the N-terminal and C-terminal boundaries of the TM domain, respectively.
The crude peptide (5-15 mg) was purified by reverse-phase HPLC on a C4 column using gradient elution. The gradient starts with a largely aqueous solution of 70% distilled water, 12% acetonitrile, and 18% 2-propanol, and is changed to a more hydrophobic composition of 40% acetonitrile and 60% 2-propanol that elutes the peptides. The elution was monitored by the optical absorbance at 260 nm. The solutions corresponding to the peaks were collected into several fractions that were then lyophilized and checked by mass spectrometry for purity.
Purified gp55-P peptides were reconstituted by detergent dialysis by first dissolving DMPC, lyophilized peptide, and detergent (octyl-ß-glucoside) in trifluoroethanol. This mixture was incubated at 37°C for over 2 h, and the trifluoroethanol was removed by evaporation using a stream of argon gas and then placing the sample under vacuum. The dry mixture was 7 rehydrated with phosphate buffer (10 mM phosphate and 50 mM NaCl, pH 7.4), such that the final concentration of octyl-ß-glucoside was 5% (w/v). The rehydrated sample was then stirred slowly for at least 6 h, and the octyl-ß-glucoside was removed by dialysis using Spectra-Por dialysis tubing (3500 MW cutoff) for 24 h against phosphate buffer at 37°C. The samples were then pelleted, lyophilized, and rehydrated with deuterium-depleted water (50 ± 5% weight) and incubated at 37°C for 24 h. The reconstituted membranes were pelleted to form multilamellar dispersions and loaded into NMR rotors.
To characterize the influence of the hydration level on the deuterium spectrum, parallel samples were run of Leu396 at 40% and 60% deuterium-depleted water (by weight). The relative intensities of the MAS sidebands were not significantly different between these samples (data not shown).
Polarized IR spectroscopy.
Polarized attenuated total reflection (ATR) Fourier transform infrared (FTIR) spectra were obtained on a Bruker IFS 66V/S spectrometer. Multilamellar vesicle dispersions at a concentration of 10 mg lipid/mL were layered on a germanium internal reflection element using a slow flow of air directed at an oblique angle to the ATR plate to form an oriented multilamellar lipid-peptide film. Each sample spectrum represents the average of 1000 scans acquired at a resolution of 4 cm -1 .
The dichroic ratio (R ATR ) is defined as the ratio between absorption of parallel (A || ) and perpendicular (A^) polarized light (29) . The observed dichroic ratio is used to calculate the order parameter S meas using the equation,
Order parameters (S meas ) of 1.0 and -0.5 correspond to helical orientations parallel and perpendicular to the membrane normal, respectively. The order parameter depends on the electric field amplitudes, E x = 1.399, E y = 1.514 and E z = 1.621, in the thick film limit which is applicable for our experiments. q is the angle between the helix director and the normal of the internal-reflection element, and a is the angle between the helix director and the transitiondipole moment of the amide I vibrational mode.
In order to calculate the angle q between the helix director and the normal of the ATR plate, one must know the value of the transition moment angle a. There has been a wide range of values for a reported in the literature over the years (e.g. 20° (30) to 40° (31) ) due to the lack of good model systems for polarized IR studies where the orientation and disorder of the amide bonds were known independently from the IR measurements. Recently, Marsh and coworkers have converged on a value of a in two very different systems: 38° for a block co-polymer (poly(g-methyl-L-glutamate) x -co-(g-n-octadecyl-L-glutamate) y (32) and 39.5° for the membrane protein bacteriorhodopsin (33) . These results indicate that the transition moment angle for the amide I vibration is independent of the specific system used. Importantly, Marsh and Pali (33) show that there are only limited structural deviations between the transmembrane helices of bacteriorhodopsin and a standard a-helix. Consequently, the value of 39.5° obtained for bacteriorhodopsin is applicable to standard helices.
We typically obtain polarized IR spectra of bacteriorhodopsin prior to measurements on reconstituted transmembrane peptides. This approach provides an independent check of our experimental setup and validates the use of 39.5° for the transition moment angle a.
Bacteriorhodopsin is an integral membrane protein that forms two-dimensional crystalline arrays that orient well on germanium ATR surfaces. The disorder in orientation typically corresponds to an S mem of 0.8 -0.9 based on measurements of mosaic spread (30). Since we cannot independently measure the disorder in the orientation of our reconstituted transmembrane peptides, we use a value of S mem equal to 0.85 as the upper limit in our calculations. We assume that the disorder in the gp55-P sample is equal to the disorder in bacteriorhodopsin. If the disorder is greater in our reconstituted sample, then the measured dichroic ratio will be less than the true dichroic ratio, and the true crossing angle will be smaller for the gp55-P helices.
One way to indirectly assess the quality of our reconstitutions is to measure the dichroic ratios of the lipids. Dichroic ratios of the asymmetric and symmetric lipid CH 2 stretching modes at 2924 cm -1 and 2852 cm -1 were 1.15 and 1.10, respectively, which correspond to order parameters of 0.65 and 0.67, and are consistent with well-oriented lipids (34) .
NMR spectroscopy.
Deuterium NMR spectra were obtained at a 2 H frequency of 55.26 MHz using magic angle spinning. MAS spectra yield much higher sensitivity compared to conventional static spectra in membrane-reconstituted samples where the concentration of deuterated peptide is low. A MAS frequency of 3 kHz was used to have a sufficient number of spinning side bands to define the static lineshape. Single pulse excitation was employed using a 3.7-µs 90° pulse, followed by a 4.5-µs delay before data acquisition. The repetition delay was 250 ms. A total of 600,000-800,000 transients were averaged for each spectrum and processed using a 200-Hz exponential line broadening function. Spectra were obtained at 25°C.
MAS deuterium spectra were simulated using the program SIMPSON version 1.1.0 (35) with a spin rate of 3.0 kHz. The asymmetry parameter (h) was set to 1.0. Only the quadrupole coupling constant was varied to quantify the breadth of the lineshape
Computational searches.
The computational search strategy using the program CHI has been described previously (36) . Low-energy conformations of helix dimers were searched by rotating each helix through rotation angles j 1 and j 2 from 0° to 360° with a sampling step sizes of 25-45° and with interhelical separations of 9.5 Å, 10.0 Å and 10.5 Å. The j 1 and j 2 angles are equivalent to the a and b angles originally described by Adams et al. (36) . MD simulations were run with simulated annealing at each rotational orientation of the dimer using the program X-PLOR along with the united atom topology and parameters sets, TOPH19 and PARAM19, respectively.
Calculations were carried out for helices with both left-and right-handed geometries with initial crossing angles of 25°. Four different runs were carried out for each starting geometry using torsional angle dynamics. The rotation and crossing angles were allowed to vary during the simulations. To maintain an a-helical conformation, distance restraints were applied between O i and N i+4 atoms along the backbone.
Results and Discussion
Peptides corresponding to the TM domains of membrane proteins are able to independently fold and associate in membrane bilayers (37) . To determine the structure of the TM dimer of gp55-P, we first establish that gp55-P TM peptides adopt an a-helical TM conformation in bilayers using polarized IR spectroscopy. Second, deuterium NMR spectroscopy of gp55-P containing specifically 2 H-labeled leucine is used to establish the rotational orientation and crossing angle of the TM helices. Third, computational searches are undertaken to generate possible low energy dimer structures that are consistent with the IR and NMR data.
Transmembrane a-helical structure of gp55-P. There are several advantages of deuterium MAS spectroscopy as a structural method for mapping out the helix interfaces of oligomeric membrane peptides and proteins. The first advantage is that the NMR experiment used here is simple. Only one-dimensional deuterium NMR spectra need to be acquired. The pulse sequence consists of a single pulse on the deuterium channel without proton decoupling. Second, MAS greatly increases the sensitivity of the experiment which allows one to study peptides embedded into membrane bilayers at low concentration. Moreover, the MAS frequencies are slow and are readily attainable with standard MAS probes. The third advantage is that the data can be acquired over a broad temperature range, above and below the lipid phase transition temperatures. In contrast, distance measurements using rotational resonance or rotational echo double resonance (REDOR) techniques are best done at low temperature where the full dipolar couplings can be measured.
Previous deuterium NMR studies of side chain motion in TM helices have focused on leucine (25), valine (27) and alanine (26). Leucine containing a single deuterated methyl group Only subtle differences are observed in the lineshapes of valines located in interfacial and noninterfacial positions (27) .
The approach taken here is to compare spectra of deuterated leucines at different positions in the gp55-P TM helix in parallel samples. For instance, four consecutive leucines (e.g. Leu396-Leu397-Leu398-Leu399) in the TM sequence constitute one full turn of the gp55-P 13 a-helix. At least one of the leucine side chains will be facing the helix dimer interface and exhibit a broader deuterium spectrum due to restricted motion.
The intensities of the side bands in the MAS deuterium spectra trace out the broad deuterium lineshapes. The high flexibility, which makes deuterated leucine a sensitive probe of molecular motion, limits analyses of the deuterium lineshape by detailed spectral simulation. To quantify the observed differences in the width of these lineshapes, we simulate the MAS deuterium spectra using the quadrupole coupling constant as the only free parameter. The simulations assume that the lineshapes have an asymmetry parameter (h) of 1 due to high motional averaging (39) . Importantly, the simulations are simple to run using a program that is readily available (http://nmr.imsb.au.dk/bionmr/software/simpson.php).
Leu399 is in the gp55-P transmembrane dimer interface.
The strategy to determine the interface of the gp55-P dimer is to target a consecutive The gp55-P transmembrane dimer has a right-handed crossing angle.
Comparison of the deuterium spectra in Fig. 2 indicates that Leu399 is in the dimer interface of gp55-P. With a single point of contact in the center of the TM sequence, one can establish the full dimer interface if one knows whether the helices cross with a left-handed (LH) or right-handed (RH) crossing angle. Both types of configurations are common in membrane proteins (40) . The crossing angle of the two helices in the gp55-P dimer can be determined based on deuterium spectra of leucines that are positioned at the ends of the TM helices. If
Leu399 is in the interface and roughly at the crossing point of the two helices in the center of the TM sequence, then the position of Leu385 and Leu407 with respect to the interface will depend on the crossing angle (Fig. 3) . If Leu399 is in an interfacial "a" or "d" position of a left-handed coiled coil, then Leu385 would lie in an "a" or "d" position. In contrast, Leu407 would lie in a "b"
or "e" position outside of the dimer interface. In a similar fashion, in a right-handed geometry with Leu399 in the interface, Leu385 would be oriented toward the lipid and Leu407 would lie in the dimer interface.
The left column of Fig. 4 compares the deuterium NMR spectra of Leu385 and Leu407.
The spectrum of Leu385 is similar to that of Leu396, which is in a lipid-facing position, whereas the spectrum of Leu407 is similar to that of Leu399 in the dimer interface. The broader lineshape observed for Leu407 is best fit with a quadrupole coupling constant of 27 kHz. The lineshape is consistent with a right-handed geometry, and argues that the gp55-P remains helical through Leu407, which is located in the short juxtamembrane sequence of the protein.
Finally, the helix tilt determined from polarized IR experiments supports the conclusion from the deuterium NMR measurements that the gp55-P helices have a right-handed crossing angle. Based on packing considerations alone, the crossing angles for right-and left-handed helices predicted by Chothia (41) are -52° and +23°, respectively. The tilt angle of 25° relative to the bilayer normal, inferred from the amide I dichroic ratio, corresponds to a crossing angle of 50° consistent with a right-handed crossing geometry.
An important point to emphasize here is that the sign of the crossing angle (i.e. righthanded vs. left-handed) is determined from the NMR data presented in Fig. 4 . Comparison of the Leu385 and Leu407 lineshapes is consistent with a right-handed crossing angle, but is not consistent with a left-handed crossing angle. An estimate of the magnitude of the crossing angle is derived the polarized ATR-FTIR data. The calculated crossing angle of ~50° is consistent with the NMR determination that the crossing angle is right-handed. However, as noted in the Methods section the measured dichroic ratio corresponds to the maximum tilt angle of the gp55-P helix. If the reconstitution is not optimal, then the observed dichroic ratio may be lower than the true dichroic ratio. This would yield a smaller crossing angle for the gp55-P helices.
The deuterium MAS spectra and simulations also serve to emphasize two additional points. First, the simulations assume that the lineshapes have an asymmetry parameter of 1.
Both the Leu399 and Leu407 lineshapes exhibit spectra where the +/-4 side bands have greater intensity than the +/-3 side bands. These features are well reproduced in the simulations and support the assumption of h equal to 1. Second, the Leu399 and Leu407 lineshapes are remarkably similar. In both cases, the broadening of the lineshape is attributed to restriction of leucine side chain motion due to packing in the gp55-P dimer interface. This suggests that leucine motion and the associated deuterium MAS analyses are not dependent on the position of the deuterated leucine relatively to the membrane surface.
Structural model of the gp55-P transmembrane dimer.
The deuterium NMR data presented in Figs. 2 and 4 provide structural constraints for evaluating models of the gp55-P TM dimer that emerge from computational searches for low energy helix dimers (36) . The NMR constraints were not used to guide or otherwise influence the searches.
In our computational studies, low energy conformations of gp55-P helix dimers having both right-and left-handed crossing angles were searched by rotating each helix in the dimer relative to the other (see Methods). The average molecular structure of the low energy helix dimer from the symmetric cluster is shown in Fig. 6 with a helix crossing angle of ~35°. The structure provides a framework for interpreting mutational and biochemical data on gp55-P. The working model is that a stable TM dimer structure is required for activation, and that amino acids oriented away from the dimer interface interact directly with the TM domain of the Epo receptor.
First, we discuss the amino acids predicted to mediate dimerization of gp55-P. The helix interaction energy for the average molecular structure in the symmetric cluster is shown in Fig.   5B . The low energy structure is stabilized by hydrogen bonding across the dimer interface of Thr384-to-Thr384 and Thr388-to-Thr388. In simulations on gp55-P dimers having shorter axial separations (e.g. 9.5 Å), hydrogen bonding of Ser392 to the backbone of Gly391 was also observed. Decreasing the step-size during some of the conformational searches also yielded clusters that exhibited Gly391-Ser392 hydrogen bonding. The observation of Thr, Ser and Gly in the gp55-P interface is consistent with the role of small and weakly polar amino acids in mediating helix interactions in polytopic membrane proteins (42) .
There are two sites in the gp55-P dimer interface, Gly391 and Leu399, where mutation blocks the ability of gp55-P to activate the Epo receptor. Gly391 is predicted to be in the dimer interface of the right-handed gp55-P structure (Fig. 3) . Mutation of Gly391 to leucine blocks the ability of gp55-P to activate the Epo receptor (22) . Glycine often serves as a molecular notch for mediating TM helix interactions (43) . For instance, in the TM helix dimer of glycophorin A, two glycines are found in the helical interface (29, 44) and mutation of either is sufficient to disrupt dimerization (45) .
Mutation of Leu399 to isoleucine, the corresponding amino acid in gp55-A, also abolishes the ability of gp55-P to activate the Epo receptor (22) . The deuterium data in Fig. 2 clearly show that Leu399 is well packed in the dimer interface. Whereas the mutation of Leu399 to isoleucine is conservative, in glycophorin A it was found that mutation of Leu75, which is in the dimer interface, to isoleucine was sufficient to disrupt dimerization (45) . In the structural model of the gp55-P dimer, replacement of isoleucine for leucine at position 399 results in steric clash between the isoleucine b-methyl groups. The effects of mutations at similar amino acids in the dimer interfaces of gp55-P and glycophorin A suggest that a stable gp55-P dimer structure is required for activation of the Epo receptor.
The TM dimer structure of gp55-P in Fig. 6 shows that several amino acids thought to mediate TM interactions with the Epo receptor are oriented toward the lipid-interface. We have previously proposed that Met390 is oriented away from the dimer interface and interacts with Ser238 in the Epo receptor (22) . Mutation of Met390 to isoleucine, the corresponding amino acid in gp55-A, abolishes the ability to activate the Epo receptor (22) . The gp55-P dimer structure confirms our previous proposal.
The isoleucine in position 404 is not directly in the dimer interface and can tolerate substitution with Leu or Phe (22) . However, deletion of Ile404 results in loss of gp55-P-induced activation of the Epo receptor (21) . The gp55-P dimer structure in Fig. 6 orients Trp405, a large aromatic amino acid, away from the dimer interface. Deletion of Ile404 would likely change the orientation of the C-terminal end of the gp55-P helix such that Trp405 on opposing helices would rotate toward the dimer interface and clash, possibly disrupting dimerization or the local helical secondary structure. These data suggest that the short C-terminal end of gp55-P also interacts with the Epo receptor. This would not be surprising because the juxtamembrane sequence of the Epo receptor is highly conserved and has been proposed as a switch region for regulating receptor activity (46) . The deuterium NMR data, showing that Leu407 is well packed in the helical interface of gp55-P, provides compelling evidence that the end of the gp55-P helix is not unraveled and that both Trp405 and His408 are in a position to interact with the juxtamembrane sequence of the receptor.
The low energy structure of the gp55-P dimer along with the analysis of the mutations above suggests that the gp55-P dimer structure does not change upon interaction with the Epo receptor. Rather, gp55-P catalyzes the conversion of an inactive Epo receptor TM dimer to an active dimer. Deuterium MAS NMR studies are in progress to directly test this model.
Comparison of gp55-P and gp55-A suggests that novel sequences may in principle be identified that could bind and activate the Epo receptor to different extents. We plan to exploit the productive interaction between the Epo receptor and gp55-P TM domains as a selection system to design and test sequences for their ability to bind the TM domain of the Epo receptor and activate receptor signaling. Such genetic systems have previously been described only for bacteria (47-49) and could lead to new insights into specific TM interactions in mammalian cell membranes.
Finally, the TM sequence of gp55-P is almost identical to that of the fusiogenic envelope proteins of the mink cell focus-inducing viruses and murine leukemia viruses. The major exception is at position 392 where there is a conserved proline in place of Ser in gp55-P and gp55-A (50). Position 392 is relatively tolerant to mutation in gp55-P (Constantinescu, unpublished results). However, mutation of Pro392 to alanine in the fusiogenic envelope proteins blocks viral fusion with the cell membrane, but not incorporation of the envelope protein into virions (50) . Langosch and coworkers (51) have proposed that structural flexibility introduced by Pro392 is required for fusogenicity. The structure of the gp55-P TM dimer provides a basis for understanding for how small sequence differences in the TM domain between gp55-P and the viral envelope proteins affect function. The gp55 proteins are not able to mediate membrane fusion, but have evolved the capability to activate membrane receptors. to the right were carried out using the program SIMPSON version 1.1.0 (35) . The MAS rate was set to 3 kHz, the asymmetry parameter was set to 1.0 and the quadrupole coupling constant was changed to 16 kHz and 27 kHz to obtain the best fit to the side band intensities of Leu385 and Leu407, respectively. 
Figure Legends
